Compounded Semaglutide Quality: How Pharmacies Are Tested
Introduction
Compounded semaglutide quality is verified through batch testing for potency, sterility, and endotoxin levels, conducted on samples from each compounding lot. Reputable 503A pharmacies test in-house and send samples to independent third-party labs. USP requires sterile compounded preparations to be 90% to 110% of label claim for potency. Sterility testing follows USP <71>. Endotoxin testing follows USP <85>. Pharmacies that publish or share certificates of analysis on request are operating transparently. Pharmacies that won’t share testing aren’t.
Independent testing of compounded GLP-1 by Valisure and academic groups since 2023 has found a meaningful minority of samples outside USP limits or containing salt-form API rather than the approved semaglutide base. The variation across pharmacies is large. Quality isn’t a property of the category. It’s a property of the specific pharmacy.
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.
What Does “Quality Testing” Actually Mean for Compounded Semaglutide?
Quality testing covers four properties of the finished compounded vial:
Quick Answer: Reputable compounded semaglutide is tested for potency, sterility, and endotoxin per batch
Identity. Is the active ingredient actually semaglutide base (not a salt form, not a different peptide)?
Potency. How many milligrams of semaglutide per mL are in the vial, and does it match the label?
Sterility. Is the vial free of bacterial and fungal contamination?
Endotoxin. Are bacterial cell wall fragments below USP’s injection limits?
A complete quality program covers all four. Some pharmacies do potency and sterility but skip endotoxin. Some skip identity testing and assume API supplier paperwork is sufficient. The most thorough programs do all four on every batch.
How Is Potency Tested?
High-performance liquid chromatography (HPLC) is the standard analytical method for semaglutide potency. The technique separates semaglutide from other compounds in the vial and quantifies the amount by detector response.
HPLC for semaglutide typically uses a C18 reverse-phase column with UV detection at 214 nm. Reference standards from the API supplier or USP allow calibration. Results report as percentage of label claim. USP requires 90% to 110% for sterile compounded preparations.
A potency result of 85% means the vial has 15% less semaglutide than the label says. A patient drawing the labeled dose volume would get an under-dose. A result of 115% means the patient gets an overdose, which drives more side effects.
Both ends of the deviation matter clinically. Both should fail batch release.
How Is Sterility Tested?
USP <71> sterility testing requires inoculating samples of the compounded product into culture media (fluid thioglycolate medium for anaerobes, soybean-casein digest medium for aerobes and fungi) and incubating for 14 days. Growth indicates contamination.
The challenge with USP <71> testing is the 14-day window. Compounded semaglutide multi-dose vials typically have beyond-use dating of 30 to 90 days. Waiting 14 days for sterility results before dispensing means the patient gets the vial later, and the remaining shelf life is shorter.
Reputable pharmacies use rapid sterility methods (Celsis, BacT/ALERT, or similar) that detect contamination in 5 to 7 days, allowing faster release while still complying with USP standards. Some pharmacies do a release based on validated rapid methods and confirm with USP <71> retrospective testing.
How Is Endotoxin Tested?
USP <85> bacterial endotoxin testing uses the LAL (limulus amebocyte lysate) assay or a recombinant Factor C method. Endotoxins are bacterial cell wall fragments that can cause fever and serious adverse reactions when injected even at low concentrations.
The acceptance limit depends on the dose. For semaglutide, the maximum endotoxin per dose follows USP general guidance for injectable products.
Endotoxin testing is fast (results in hours, not days) and is part of every reputable batch release process.
What Does USP <797> Add on Top of Testing?
USP <797> is the compounding standard for sterile preparations. It defines the environment in which compounding happens: ISO 5 air quality in the immediate compounding zone, ISO 7 ante-room, garbing, environmental monitoring, beyond-use dating, and personnel training.
USP <797> compliance reduces the chance of contamination during compounding. Combined with sterility testing on the finished product, it creates a layered defense against contaminated vials reaching patients.
State boards of pharmacy adopt USP <797> as the standard. Pharmacies operating outside <797> are noncompliant and unsafe for sterile compounded preparations.
What’s the Difference Between In-house and Third-party Testing?
In-house testing means the pharmacy runs the analytical methods on its own equipment using its own staff. It’s the baseline for quality control and is required by USP standards.
Third-party testing means an independent lab unaffiliated with the pharmacy runs the analysis on samples sent from the pharmacy. It’s more credible because the lab has no incentive to release a failing batch.
Reputable pharmacies do both. In-house testing for routine batch release. Third-party testing for periodic verification, often quarterly or annually, with results published to patients.
Pharmacies that only do in-house testing aren’t necessarily unsafe, but they’re not maximally transparent.
Key Takeaway: Sterility testing follows USP <71> with 14-day incubation
What’s a Certificate of Analysis (COA) and How Do I Read One?
A COA documents the testing results for a specific batch. A useful COA includes:
Batch (lot) number matching your vial label.
Product description (e.g., “Semaglutide 5 mg/mL Injectable Solution”).
Compounding date.
Beyond-use date.
Test specifications (acceptance criteria like 90-110% potency).
Test results (actual measured values).
Test methods used (USP method numbers).
Testing lab name and accreditation.
Authorized signatory.
A vague COA with “passes specifications” but no actual numbers isn’t useful. A specific COA with measured values, dates, and lab identity is.
Reputable pharmacies provide COAs on request or publish them in a patient portal.
What Testing Failures Have Happened with Compounded Semaglutide?
Independent testing by Valisure and academic groups since 2023 has found:
Potency outside USP limits (some samples under 90%, some over 110%).
Salt-form API (semaglutide sodium, semaglutide acetate) sold as if it were the approved base.
Failed sterility on a small percentage of samples.
Mislabeled products (wrong concentration, wrong peptide entirely in research-grade samples).
The failures cluster at the sketchy end of the market: international vendors, research-peptide sellers, and US pharmacies later disciplined by state boards. Compliant 503A pharmacies operating with documented quality programs have generally passed independent testing.
How Can I Verify My Compounded Semaglutide Is High Quality?
Five checks:
Pharmacy license: state board of pharmacy public license lookup, active status.
503A or 503B status confirmed in writing.
Semaglutide base API confirmed in writing (not sodium, not acetate).
Batch COA for your dispensed batch available on request.
Cold-chain delivery with ice pack still cool on arrival.
If all five pass, the product is likely high quality. If any fails, escalate to the pharmacist or consider switching pharmacies.
What Does TrimRx Do for Quality Assurance?
TrimRx partners with US state-licensed 503A pharmacies that source semaglutide base API from FDA-registered suppliers, follow USP <797> sterile compounding, and test each batch for potency, sterility, and endotoxin. Third-party testing is documented and available on request. Cold-chain shipping uses temperature-controlled packaging with documentation.
The free assessment quiz routes patients to appropriate partner pharmacies. Patient support can provide batch certificates of analysis for dispensed lots.
Are There Published Standards for Compounded Semaglutide Quality?
Yes, layered:
USP General Chapter <797> for sterile compounding environment and processes.
USP General Chapter <71> for sterility testing.
USP General Chapter <85> for endotoxin testing.
State board of pharmacy regulations for licensure, inspection, and disciplinary standards.
FDA section 503A requirements for compound legitimacy.
Pharmacies in the legitimate compounded GLP-1 market follow all of these. The market also has actors operating outside these standards.
Bottom line: Patients can request a certificate of analysis for their specific dispensed batch
FAQ
Can I Get My Own Compounded Semaglutide Independently Tested?
Yes. Several independent labs accept consumer samples for potency and identity testing. Costs run $200 to $400 per test. Most patients find requesting the pharmacy’s COA more practical.
Does the FDA Test Compounded Semaglutide?
The FDA tests samples during inspections and warning letter investigations but doesn’t routinely test commercial compounded products. Manufacturer testing and independent lab testing fill more of the gap.
What’s the Worst Quality Failure That’s Been Reported?
Salt-form API sold as the approved active ingredient is the most common quality failure. Sterility failures and gross potency variations have also been documented in independent testing.
Is In-house Testing Enough?
It’s the minimum. Third-party verification adds credibility. Pharmacies doing both are more transparent than pharmacies doing only in-house.
What Does a Passing Potency Result Look Like?
Within 90% to 110% of label claim per USP standards. A vial labeled 5 mg/mL with a measured potency of 4.8 mg/mL (96%) passes. A measured 4.3 mg/mL (86%) fails.
How Long Is a COA Valid?
The COA is for the specific batch it tests, not a time period. As long as the vial is from that batch, the COA applies. Stability over the beyond-use dating period is a separate validation.
What Should I Do If My COA Shows Out-of-spec Results?
Contact the pharmacy immediately. A reputable pharmacy will issue a replacement and investigate the batch. Out-of-spec results shouldn’t reach patients, so finding them in your COA suggests the pharmacy’s batch release controls failed.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.
Related Articles
Transforming Lives, One Step at a Time
Keep reading
Semaglutide for Seniors: Safety, Dosing, and What to Expect
Adults 65 and older are one of the fastest-growing groups seeking GLP-1 medications, and for good reason. Obesity in older adults is associated with…
Can You Take Semaglutide Forever? What Long-Term Use Looks Like
It’s one of the most common questions patients ask once semaglutide starts working: do I have to stay on this forever? The question cuts…
Why Compounded Semaglutide Is Cheaper Than Brand
Compounded semaglutide costs less than Ozempic and Wegovy because the pricing covers different things.
